BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23722901)

  • 1. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
    Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
    J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
    Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
    PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
    Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
    Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
    Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
    J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glucocorticoid activation during mouse skin wound healing.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    J Endocrinol; 2014 Apr; 221(1):51-61. PubMed ID: 24464022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.
    Terao M; Murota H; Kimura A; Kato A; Ishikawa A; Igawa K; Miyoshi E; Katayama I
    PLoS One; 2011; 6(9):e25039. PubMed ID: 21949844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.
    Kim BJ; Lee NR; Lee CH; Lee YB; Choe SJ; Lee S; Hwang HJ; Kim E; Lavery GG; Shin KO; Park K; Choi EH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction.
    Lee YB; Hwang HJ; Kim E; Lim SH; Chung CH; Choi EH
    Sci Rep; 2023 Jun; 13(1):9206. PubMed ID: 37280272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticosteroids in skin physiology and therapeutic potential of an 11β-HSD1 inhibitor: A review.
    Hall L; Hart R
    Int J Dermatol; 2024 Apr; 63(4):443-454. PubMed ID: 38146184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
    Lee SE; Lee EY; Kang SJ; Lee SH
    Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.
    Doig CL; Fletcher RS; Morgan SA; McCabe EL; Larner DP; Tomlinson JW; Stewart PM; Philp A; Lavery GG
    Endocrinology; 2017 Jun; 158(6):1964-1976. PubMed ID: 28368470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
    Morgan SA; McCabe EL; Gathercole LL; Hassan-Smith ZK; Larner DP; Bujalska IJ; Stewart PM; Tomlinson JW; Lavery GG
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2482-91. PubMed ID: 24889609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation.
    Hardy RS; Filer A; Cooper MS; Parsonage G; Raza K; Hardie DL; Rabbitt EH; Stewart PM; Buckley CD; Hewison M
    Arthritis Res Ther; 2006; 8(4):R108. PubMed ID: 16846535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.
    Lee NR; Kim BJ; Lee CH; Lee YB; Lee S; Hwang HJ; Kim E; Kim SH; Lee MG; Lee SE; Lavery GG; Choi EH
    Sci Rep; 2020 Nov; 10(1):20237. PubMed ID: 33214595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing.
    Brazel CB; Simon JC; Tuckermann JP; Saalbach A
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin 11β-hydroxysteroid dehydrogenase type 1 enzyme expression regulates burn wound healing and can be targeted to modify scar characteristics.
    Tsai KH; Shi H; Parungao RJ; Naficy S; Ding X; Ding X; Hew JJ; Wang X; Chrzanowski W; Lavery GG; Li Z; Issler-Fisher AC; Chen J; Tan Q; Maitz PK; Cooper MS; Wang Y
    Burns Trauma; 2023; 11():tkac052. PubMed ID: 36694861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.